Park, Inkeun
Lee, Hyo Jin
Bae, Woo Kyoon
Yoon, Shinkyo
Lee, Jae Lyun
Article History
Received: 18 April 2019
Accepted: 11 June 2019
First Online: 24 June 2019
Compliance and ethical standards
:
: Inkeun Park received honoraria for consulting or advisory roles from Pfizer Korea, Eisai Korea, Bristol-Myers Squibb pharma Korea, Astellas Pharma Korea, Janssen Korea, and iPSEN Korea. Jae Lyun Lee received honoraria for consulting or advisory roles from Pfizer Korea, Eisai Korea, Sanofi-Aventis Korea, Bristol-Myers Squibb Korea, Astellas Pharma, and Amgen Korea, and his institution received research funds from Pfizer, grants from Janssen, grants from Novartis, grants from Bristol-Myers Squibb, grants from Reche/Genentech, grants from AstraZeneca/MedImmune, grants from MSD.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: This study was approved by the institutional review board of each participating centers and Informed consent was obtained from all individual participants included in the study.